Fluvoxamine is used in OCD, and social anxiety disorder. It is sold under the brand name Luvox. It is also used to treat depression and such as panic disorder, post-traumatic stress disorder. Reference standards of Fluvoxamine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Fluvoxamine
Catalogue No.:PA 06 89000
CAS :
Molecular Formula : C15H21F3N2O2
Molecular Weight : 318.33
Valerophenone
Catalogue No.:PA 06 89510
Molecular Formula : C11H14O
Molecular Weight : 162.23
5-Methoxy-1-(4(difluoromethyl)phenyl)-1-pentanone-o-(2-aminoethyl)oxime Maleate
Catalogue No.:PA 06 87510
Molecular Formula : C19H26F2N2O6
Molecular Weight : 416.42
Fluvoxamine Maleic Acid Monoamide Impurity
Catalogue No.:PA 06 87520
Molecular Formula : C19H23F3N2O5
Molecular Weight : 416.39
(E)-1-(4-(Trifluoromethyl)phenyl)pentan-1-one O-(2-((2-aminoethyl)amino)ethyl) oxime Maleate
Catalogue No.:PA 06 87530
Molecular Formula : C20H28F3N3O5
Molecular Weight : 447.45
2-Aminoethoxy-d4-amine Dihydrochloride
Catalogue No.:PA STI 006080
Molecular Formula : C2H6D4Cl2N2O
Molecular Weight : 153.04
N-Boc Fluvoxamine-d3
Catalogue No.:PA STI 013960
Molecular Formula : C20H26D3F3N2O4
Molecular Weight : 421.47
N-(2-Bromoethyl-d4)phthalimide
Catalogue No.:PA STI 014710
Molecular Formula : C10H4D4BrNO2
Molecular Weight : 258.10
N-(2-(1,3-Dioxoisoindolin-2-yl)ethoxy-d4)benzamide
Catalogue No.:PA STI 035420
Molecular Formula : C17H10D4N2O4
Molecular Weight : 314.33
(E)-Fluvoxamine-d3 Maleate
Catalogue No.:PA STI 042600
Molecular Formula : C19H22D3F3N2O6
Molecular Weight : 437.43
(E)-Fluvoxamine-d4 Maleate
Catalogue No.:PA STI 042610
Molecular Formula : C19H21D4F3N2O6
Molecular Weight : 438.43
4-Oxo-10-[4-(trifluoromethyl)phenyl]-8,15-dioxa-5,9-diazahexadeca-2,9-dienoic acid
Catalogue No.:PA 06 87540
Molecular Weight : 416.4
N-Acetyl Fluvoxamine Acid
Catalogue No.:PA 06 89520
Molecular Formula : C16H19F3N2O4
Molecular Weight : 360.33
Catalogue No.:PA IPIPRS 103 14
Molecular Formula :
Molecular Weight : NA
Fluvoxamine Maleate (JP 0091)
Catalogue No.:PA JP0091
Molecular Formula : NA
Fluvoxamine for system suitability (Y0000853)
Catalogue No.:PA EPY0000853
Fluvoxamine maleate (Y0000854)
Catalogue No.:PA EPY0000854
Fluvoxamine impurity D (Y0000916)
Catalogue No.:PA EPY0000916
Fluvoxamine Maleate (1285909)
Catalogue No.:PA USP1285909
fluvoxamine maleate (600RB)
Catalogue No.:PA BP600RB
fluvoxamine maleate impurity standard (671RB)
Catalogue No.:PA BP671RB
Fluvoxamine Acid
Catalogue No.:PA 06 89530
Molecular Formula : C14H17F3N2O3
Molecular Weight : 318.3
N-[4-(Trifluoromethyl)benzoyl]glycine
Catalogue No.:PA 06 89540
Molecular Formula : C10H8F3NO3
Molecular Weight : 247.17
α-[4-(Trifluoromethyl)phenyl]benzeneethanol
Catalogue No.:PA 06 89550
Molecular Formula : C15H13F3O
Molecular Weight : 266.3
(E)-1-(4-(Trifluoromethyl)phenyl)pentan-1-one O-(2-((2-aminoethyl)amino)ethyl) Oxime
Catalogue No.:PA 06 0871000
Molecular Formula : C16H24F3N3O
Molecular Weight : 331.38
5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentan-1-one oxime
Catalogue No.:PA 06 0891000
Molecular Formula : C13H16F3NO2
Molecular Weight : 275.27
Aminoethyl Desmethoxy Fluvoxamine Dimaleate
Catalogue No.:PA 06 0871001
Molecular Formula : C24H32F3N3O9
Molecular Weight : 563.53
(E)-N-(2-(((5-Methoxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)-N-nitrosoaspartic Acid
Catalogue No.:PA 06 0891001
Molecular Formula : C19H24F3N3O7
Molecular Weight : 463.41
(E)-N-(2-Aminoethyl)-N-(2-(((5-methoxy-1-(4-(trifluoromethyl)phenyl)pentylidene)amino)oxy)ethyl)nitrous Amide
Catalogue No.:PA 06 0891002
Molecular Formula : C17H25F3N4O3
Molecular Weight : 390.41
Desfluoro Fluvoxketone
Catalogue No.:PA 06 0891003
Molecular Formula : C13H16F2O2
Molecular Weight : 242.27
(E)-5-Methoxy-1-(2-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime
Catalogue No.:PA 06 0891004
Molecular Weight : 318.34
(E)-5-Methoxy-1-(3-(trifluoromethyl)phenyl)pentan-1-one O-(2-aminoethyl) oxime
Catalogue No.:PA 06 0891005
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
